Liminatus Pharma
(NASDAQ) LIMN
Liminatus Pharma Financials at a Glance
Market Cap
$8.41M
Revenue (TTM)
$0.00
Net Income (TTM)
$9.88M
EPS (TTM)
$-0.36
P/E Ratio
-0.51
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$0.19
Volume
18,805
Open
$0.19
Price
$0.19
Volume
18,805
Open
$0.19
Previous Close
$0.19
Daily Range
$0.19 - $0.19
52-Week Range
$0.16 - $33.66
Dividend
$0.00
Beta (Volatility)
1.01 (Average)
Price
$0.19
Volume
18,805
Open
$0.19
Previous Close
$0.19
Daily Range
$0.19 - $0.19
52-Week Range
$0.16 - $33.66
LIMN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Liminatus Pharma
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Chris Kim
Website
liminatuspharma.comHeadquarters
La Palma, CA 90623, US
LIMN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
28%
Return on Assets
-19%
Earnings Yield
-1.96%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.41M
Shares Outstanding
44.88M
Volume
18.80K
Short Interest
0.00%
Avg. Volume
8.90M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$2.97M
EBITDA
$9.99M
Operating Cash Flow
$9.96M
Capital Expenditure
$13.11K
Free Cash Flow
$9.98M
Cash & ST Invst.
$337.65K
Total Debt
$1.44M
Liminatus Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$8.41M
N/A
Market Cap/Employee
$2.80M
N/A
Employees
3
N/A
Net Income
$8.17M
-840.8%
EBITDA
$8.15M
-1018.6%
Quarterly Fundamentals
Net Cash
$1.10M
+74.4%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.44M
-71.8%
Return on Assets
-19.27%
N/A
Return on Invested Capital
27.63%
N/A
Free Cash Flow
$386.85K
+50.8%
Operating Cash Flow
$386.85K
+50.8%